Clinical trial / 2016
Eliminating cow's milk led to significant histologic and symptomatic improvement comparable to swallowed fluticasone in pediatric eosinophilic esophagitis.
A prospective comparative effectiveness trial compared cow's milk elimination (n = 20) with swallowed fluticasone (n = 24) in newly diagnosed pediatric patients with eosinophilic esophagitis (EoE). After 6-8 weeks, peak esophageal eosinophil counts dropped below 15 eosinophils/high-power field in 64% of the cow's milk elimination group and 80% of the fluticasone group (P = 0.4). In the milk elimination group, mean PedsQL EoE Module total scores improved from 69 to 82 (P < 0.005) and Total Symptoms scores improved from 58 to 75 (P = 0.001). For swallowed fluticasone, scores also significantly improved (Module: 64 to 75, P < 0.05; Symptoms: 58 to 69, P < 0.01).
- Study type
- Prospective comparative effectiveness trial
- Who was studied
- 44 newly diagnosed pediatric EoE patients aged 2-18 years (24 treated with swallowed fluticasone, 20 with cow's milk elimination)
- What was measured
- Repeat esophageal biopsy at 6-8 weeks and change in PedsQL EoE Module and Symptoms Scales
THE PAPER
Prospective, comparative effectiveness trial of cow's milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis.
Kruszewski PG, Russo JM, Franciosi JP, Varni JW, Platts-Mills TA, Erwin EA. Dis Esophagus, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.